Topics
Astrocytoma | Prognosis | IDH mutation
Home > Publications > Topics > Astrocytoma > Prognosis > IDH mutation
Dipasquale A, Franceschi E, Giordano L, Maccari M, Barigazzi C, Di
Nunno V, Losurdo A, Persico P, Di Muzio A, Navarria P, Pessina F,
Padovan M, Santoro A, Lombardi G, Simonelli M.
Dissecting
the prognostic signature of patients with astrocytoma isocitrate
dehydrogenase-mutant grade 4: a large multicenter, retrospective
study.
ESMO
Open. 2024 Jun 3;9(6):103485. doi:
10.1016/j.esmoop.2024.103485. PMID:
38833969. Observational study. ˍ
Ahmeti H, Kiese D, Freitag-Wolf S, Kalab M, Röcken C, Jansen
O, Mehdorn MH, Synowitz M.
IDH1
mutation is associated with improved resection rates,
progression-free survival and overall survival in patients with
anaplastic astrocytomas.
J
Neurooncol. 2024 Jun 23. doi:
10.1007/s11060-024-04743-x. PMID:
38909340. Observational study˰
ˍ